Skip to main content

Recombinant Human Thrombopoietin (E. coli-expressed), CF

R&D Systems, Inc. a Bio-Techne Brand

Earn double rewards for reviews
Recombinant Human Thrombopoietin (E. coli-expressed) Bioactivity
Recombinant Human Thrombopoietin (E. coli-expressed) SDS-PAGE
Catalog #
Size / Price
Setting the standard in quality research reagents

Key Product Details

Source: E. coli
Accession #: NP_000451
Applications: Bioactivity

Citations for Recombinant Human Thrombopoietin (E. coli-expressed), CF

Please visit our Instrument Citation Database to search our collection of scientific articles that feature our instruments.

FAQs for Recombinant Human Thrombopoietin (E. coli-expressed), CF

  • What are the differences between the Recombinant Human Thrombopoietin/Tpo Proteins (Catalog #s 288-TP, 288-TPN, and 288-TPE)?

    Each of these proteins is produced using a different expression system. 288-TP is Spodoptera frugiperda, Sf21 baculovirus-derived; 288-TPN is mouse myeloma cell line, NS0-derived; and 288-TPE is E. coli-derived.

    Additionally, the sequence length also varies. 288-TP and 288-TPN begin at Ser22 and end at Gly353. 288-TPE also begins at Ser22 but is truncated at the C-terminus, ending at Leu195. Truncation of the C-terminus has been shown to enhance the biological activity of Tpo. 

Product Documents for Recombinant Human Thrombopoietin (E. coli-expressed), CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.